Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history

被引:19
作者
Welsh, Megan L. [1 ,2 ]
Buist, Diana S. M. [1 ,2 ,3 ]
Bowles, Erin J. Aiello [3 ]
Anderson, Melissa L. [3 ]
Elmore, Joann G. [2 ,4 ]
Li, Christopher I. [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[4] Univ Washington, Dept Internal Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
Breast cancer risk; Family history; Population-based; Tumor subtype; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; EXPRESSION; OVARIAN; AGE;
D O I
10.1007/s10549-008-0026-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Many studies that have estimated the breast cancer risk attributable to family history have been based on data collected within family units. Use of this study design has likely overestimated risks for the general population. We provide population-based estimates of breast cancer risk and different tumor subtypes in relation to the degree, number, and age at diagnosis of affected relatives. Methods Cox Proportional Hazards to calculate risks (hazard ratios; 95% confidence interval) of breast cancer and tumor subtypes for women with a family history of breast cancer relative to women without a family history among a cohort of 75,189 women age a parts per thousand yen40 years of whom 1,087 were diagnosed with breast cancer from June 1, 2001-December 31, 2005 (median follow-up 3.16 years). Results Breast cancer risk was highest for women with a first-degree family history (1.54; 1.34-1.77); and did not differ substantially by the affected relative's age at diagnosis or by number of affected first-degree relatives. A second-degree family history only was not associated with a significantly increased breast cancer risk (1.15; 0.98-1.35). There was a suggestion that a positive family history was associated with risk of triple positive (Estrogen+/Progesterone+/HER2+) and HER2-overexpressing tumors. Conclusions While a family history of breast cancer in first-degree relatives is an important risk factor for breast cancer, gathering information such as the age at diagnosis of affected relatives or information on second-degree relative history may be unnecessary in assessing personal breast cancer risk among women age a parts per thousand yen40 years.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 42 条
[1]  
Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558
[2]   Familial breast and ovarian cancer:: A Swedish population-based register study [J].
Anderson, H ;
Bladström, A ;
Olsson, H ;
Möller, TR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (12) :1154-1163
[3]  
[Anonymous], 2005, STAT STAT SOFTW REL
[4]  
[Anonymous], 1999, Applied Survival Analysis: Regresyon Modelling of Time to Event Data
[5]  
[Anonymous], 1984, Analysis of Survival Data
[6]  
[Anonymous], 2003, BREAST IM REP DAT SY
[7]   Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease [J].
Beral, V ;
Bull, D ;
Doll, R ;
Peto, R ;
Reeves, G .
LANCET, 2001, 358 (9291) :1389-1399
[8]   FAMILY HISTORY, AGE, AND RISK OF FATAL BREAST-CANCER [J].
CALLE, EE ;
MARTIN, LM ;
THUN, MJ ;
MIRACLE, HL ;
HEATH, CW .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (09) :675-681
[9]   Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[10]   Risk factors for breast cancer according to estrogen and progesterone receptor status [J].
Colditz, GA ;
Rosner, BA ;
Chen, WY ;
Holmes, MD ;
Hankinson, SE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (03) :218-228